222 related articles for article (PubMed ID: 4155238)
1. The effect of L-DOPA on brain polysomes and protein synthesis: probable mediation by intracellular dopamine.
Weiss BF; Roel LE; Munro HN; Wurtman RJ
Adv Neurol; 1974; 5():87-99. PubMed ID: 4155238
[No Abstract] [Full Text] [Related]
2. Participation of dopamine- and serotonin- receptors in the disaggregation of brain polysomes by L-dopa and L-5-HTP.
Weiss BF; Liebschutz JL; Wurtman RJ; Munro HN
J Neurochem; 1975 Jun; 24(6):1191-5. PubMed ID: 1079238
[No Abstract] [Full Text] [Related]
3. Inhibition of dopa decarboxylation by RO4-4602, MK 485 and MK 486 in human liver homogenates.
Vogel WH; Mahoney K; Hare TA
Arch Int Pharmacodyn Ther; 1972; 198(1):85-93. PubMed ID: 4538242
[No Abstract] [Full Text] [Related]
4. Effect of L-DOPA and analogues on central dopamine and noradrenaline mechanisms.
Andén NE; Engel J
Adv Neurol; 1974; 5():317-24. PubMed ID: 4613158
[No Abstract] [Full Text] [Related]
5. Inhibition of DOPA accumulation by rat brain at critical L-DOPA circulating concentrations.
Horst WD; Bautz G; Renyi E; Spirt N
Adv Neurol; 1974; 5():369-73. PubMed ID: 4440584
[No Abstract] [Full Text] [Related]
6. In vivo inhibition of rat brain protein synthesis by L-dopa.
Roel LE; Schwartz SA; Weiss BF; Munro HN; Wurtman RJ
J Neurochem; 1974 Jul; 23(1):233-9. PubMed ID: 4852386
[No Abstract] [Full Text] [Related]
7. L-dopa hypotension in dogs: evidence for mediation through 5-HT release.
Antonaccio MJ; Robson RD
Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):89-102. PubMed ID: 4281293
[No Abstract] [Full Text] [Related]
8. Effect of L-dopa pretreatment on in vivo protein synthesis in various rat brain regions.
Roel LE; Levine P; Rubin D; Markovitz D; Munro HN; Wurtman RH
Life Sci; 1978 Jun; 22(21):1887-91. PubMed ID: 672434
[No Abstract] [Full Text] [Related]
9. Dopamine: mediator of brain polysome disaggregation after L-dopa.
Weiss BF; Munro HN; Ordonez LA; Wurtman RJ
Science; 1972 Aug; 177(4049):613-6. PubMed ID: 4403139
[TBL] [Abstract][Full Text] [Related]
10. Studies on the mechanism of the L-3,4-dihydroxyphenylalanine-induced decrease in tyrosine hydroxylase activity.
Dairman W; Udenfriend S
Mol Pharmacol; 1972 May; 8(3):293-9. PubMed ID: 4402746
[No Abstract] [Full Text] [Related]
11. Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase.
Bartholini G; Pletscher A
J Pharmacol Exp Ther; 1968 May; 161(1):14-20. PubMed ID: 5648492
[No Abstract] [Full Text] [Related]
12. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
Ng LK; Colburn RW; Kopin IJ
J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
[No Abstract] [Full Text] [Related]
13. The role of the adrenergic system in the action of L-DOPA on brain serotonin.
Algeri S; Cerletti C
Adv Biochem Psychopharmacol; 1974; 10():257-9. PubMed ID: 4846542
[No Abstract] [Full Text] [Related]
14. Effect of L-DOPA on S-adenosylmethionine levels and norepinephrine metabolism in rat brain.
Wurtman RJ
Adv Biochem Psychopharmacol; 1972; 6():241-6. PubMed ID: 5055596
[No Abstract] [Full Text] [Related]
15. [Relationship between the antihypertensive activity of methyldopa and the appearance of its metabolites in the heart and brain of the hypertensive rat].
Cohen Y; Wepierre J; Jacquot C; Rapin J
Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):348-60. PubMed ID: 4827419
[No Abstract] [Full Text] [Related]
16. Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
Watanabe AM; Parks LC; Kopin IJ
J Clin Invest; 1971 Jun; 50(6):1322-8. PubMed ID: 5578236
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of brain protein synthesis by doses of L-DOPA that disaggregate brain polyribosomes.
Munro HN; Roel L; Wurtman RJ
J Neural Transm; 1973; 34(4):321-3. PubMed ID: 4775138
[No Abstract] [Full Text] [Related]
18. The role of brain 5-hydroxytryptamine in the central action of L-DOPA.
Maj J; Pawlowski L; Sarnek J
Adv Biochem Psychopharmacol; 1974; 10():253-6. PubMed ID: 4846541
[No Abstract] [Full Text] [Related]
19. Aromatic amino acid decarboxylase inhibitors.
Porter CC
Fed Proc; 1971; 30(3):871-6. PubMed ID: 5575298
[No Abstract] [Full Text] [Related]
20. [Pharmacology of several aromatic amino acid decarboxylase inhibitors].
Uspenskiĭ AE; Dabagov NS; Skoldinov AP
Biull Eksp Biol Med; 1978 Oct; 86(10):444-7. PubMed ID: 309344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
